CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells

Although carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) has been viewed as a tumor suppressor, increasing clinical evidence shows that high levels of CEACAM1 expression on tumors correlates with poor prognosis and high risk of metastasis. Here, we examined the consequences...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 208; no. 13; pp. 2633 - 2640
Main Authors Chen, Zhangguo, Chen, Lanfen, Baker, Kristi, Olszak, Torsten, Zeissig, Sebastian, Huang, Yu-Hwa, Kuo, Timothy T, Mandelboim, Ofer, Beauchemin, Nicole, Lanier, Lewis L, Blumberg, Richard S
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 19.12.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Although carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) has been viewed as a tumor suppressor, increasing clinical evidence shows that high levels of CEACAM1 expression on tumors correlates with poor prognosis and high risk of metastasis. Here, we examined the consequences of CEACAM1 expression on tumor cells. We show that tumor cell-associated CEACAM1 causes intracellular retention of various NKG2D ligands in mouse and human tumor cells. CEACAM1-silenced tumor cells expressed more cell surface NKG2D ligands and exhibited greater sensitivity to natural killer cell-mediated cytolysis in vitro and rejection in vivo. Our studies reveal a novel mechanism through which CEACAM1-bearing tumor cells may escape immune-surveillance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Z. Chen and L. Chen contributed equally to this paper.
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.20102575